Sex, Menopausal Status Tied to Severity of Early Lyme Disease Presentation

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

TUESDAY, March 3, 2026 -- Sex and menopausal status appear to impact serologic status and severity of early Lyme disease, according to a study published online Feb. 7 in Clinical and Experimental Medicine.

Alison W. Rebman, M.P.H., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the clinical and serologic presentation of patients with early Lyme disease by sex and by menopausal status. The analysis included 243 adult, antibiotic-naive patients with a diagnostic erythema migrans rash present.

The researchers found that when adjusting for age, Lyme disease duration, systemic steroid use, and comorbid thyroid disease, men had higher odds of testing two-tier positive (odds ratio [OR], 1.77). This difference was even more pronounced when comparing men to premenopausal women (OR, 2.93). There were no significant differences found when comparing men with postmenopausal women. When adjusting for age and Lyme disease duration, men had higher odds of being in a higher disease severity score category (OR, 1.94), especially when compared with premenopausal women (OR, 2.26). There was a trend toward higher occurrence of heart palpitations, vomiting, and photophobia among women, while sleep difficulty was higher among men.

"In the immediate acute and convalescent period, males in our study had a clinical and laboratory presentation with more apparent objective abnormalities, and we hypothesize this could be due to differences in early host-pathogen interaction," the authors write.

One author disclosed ties to the pharmaceutical industry and has a patent pending for Gene-Expression-Based Identification of Early Lyme Disease.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-04 08:45

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords